Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New PAK-4 inhibitor under development to treat gastric cancers

Jan. 2, 2012

University of Colorado prepares new histone deacetylase inhibitors

Dec. 30, 2011

Axelar advances phase II AXL-1717 trial in lung cancer

Dec. 30, 2011

Recruitment begins in phase II SyB L-0501 trial in Japan

Dec. 30, 2011

Emergent BioSolutions advances TRU-016 into phase II for leukemia indication

Dec. 30, 2011

Phase III BTOG2 trial assesses combination therapies for advanced lung cancer

Dec. 30, 2011

New suicide gene strategy shows promise as safety switch for cell therapy

Dec. 30, 2011

U.S. study describes new radiosensitizer's mode of action

Dec. 30, 2011

Progen to switch formulation of potential best-in-class heparanase inhibitor

Dec. 29, 2011

Marina Biotech and Mirna Therapeutics enter agreement for microRNA-based drugs

Dec. 29, 2011

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...